BridgeBio Pharma, Inc. (BBIO) Q3 2026 earnings results

BridgeBio Pharma, Inc. (BBIO) reported Q3 2026 results on Oct 29, 2026, 4:03:01 PM ET: GAAP EPS -$0.42 vs. -$0.56 expected (beat by 24.6%); revenue $353.17M vs. $295.75M expected (beat by 19.4%).

Analyst estimate: the average forecast before the release.

Source

Figures from the SEC 8-K filing, released Oct 29, 2026, 4:03:01 PM ET. Nexqual published them 41 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.

Year over year

Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 192.6% from $120.70M; GAAP diluted EPS was -$0.42 vs. -$0.95 (+55.8%).

Stock reaction

The results came out after the market closed. BBIO closed at $70.73 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).

Questions and answers

Did BridgeBio Pharma, Inc. beat earnings expectations?

Yes. BridgeBio Pharma, Inc. reported GAAP EPS of -$0.42 against an average analyst estimate of -$0.56 (beat by 24.6%), and revenue of $353.17M against $295.75M expected (beat by 19.4%).

What were BridgeBio Pharma, Inc.'s Q3 2026 earnings and revenue?

GAAP diluted EPS of -$0.42 and revenue of $353.17M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 192.6% from $120.70M; GAAP diluted EPS was -$0.42 vs. -$0.95 (+55.8%).

When did BridgeBio Pharma, Inc. report Q3 2026 earnings?

Oct 29, 2026, 4:03:01 PM ET, in an SEC 8-K filing (Item 2.02).

How did BBIO stock react to the earnings?

The results came out after the market closed. BBIO closed at $70.73 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).

More on BBIO

BBIO stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.

Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:08 UTC. Not investment advice.

Data source: Nexqual. Last updated: October 29, 2026 at 23:08 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt